PharmaShots | Incisive News in 3 Shots

Subscribe Now

Project ALS

Project ALS' Prosetin Receives the US FDA's Orphan Drug Designation for Amyotrophic Lateral Sclerosis

Project ALS' Prosetin Receives the US FDA's Orphan Drug Designation for Amyotrophic Lateral Sclerosis

September 7, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us